Annette Clancy

Director/Board Member at

Abcd Ltd.

72 year

82 connections

Health Technology

Consumer Services

Commercial Services

Profile

Ms. Annette V.
Clancy is an Operating Partner at Jeito Capital SASU.
She is on the Board of Directors at Abcd Ltd. Ms. Clancy was previously employed as a Non-Executive Chairman by ENYO Pharma SA, an Independent Non-Executive Director by Lysogene SA, an Independent Director by Swedish Orphan Biovitrum AB, a Chairman by ObsEva SA, a Chairman by Genable Technologies Ltd., a Non-Executive Director by Aqualis ASA /Old/, a Non-Executive Director by Silence Therapeutics Plc, and a Head-Transactions & Alliance Management by GlaxoSmithKline Plc.
She received her undergraduate degree from the University of Bath.

Latest news about Annette Clancy

05/11/24

Sobi's Nomination Committee proposes Daniel Meek as new Chairman - calls for Extraordinary General Meeting

Annette Clancy active positions

Companies	Position	Start
Abcd Ltd.	Director/Board Member	-
Jeito Capital SASU Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements.	Private Equity Investor	07/09/2026

All active positions of Annette Clancy

Former positions of Annette Clancy

Companies	Position	End
SWEDISH ORPHAN BIOVITRUM AB	Chairman	10/12/2024
ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Chairman	30/11/2023
OBSEVA SA	Chairman	09/03/2023
LYSOGENE	Chairman	21/05/2019
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases	Chairman	29/02/2016

See the detail of Annette Clancy's experience

Training of Annette Clancy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Annette Clancy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University of Bath University of Bath Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
Weifa ASA Weifa ASA Pharmaceuticals: MajorHealth Technology Manufactures non-prescription and over-the-counter pharmaceutical products	Health Technology
Spark Therapeutics Ireland Ltd. Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases	Health Technology
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care	Health Technology
ObsEva SA ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity	Health Technology
Lysogene SA Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders	Health Technology
ENYO Pharma SA ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology
Abcd Ltd.
Jeito Capital SASU Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements.	Finance